The case for & against
Bull & Bear analysis
Bullish
Bangkok Lab and Cosmetic Public Company Limited (SET: BLC) operates in the health and beauty sector, specializing in cosmetic and pharmaceutical products. The company has established itself as a key player in Thailand, recognized for its commitment to innovation and strong corporate governance. BLC is emerging in the market, benefitting from a growing health-conscious consumer base and an increasing demand for high-quality personal care products, establishing a foothold in the *sustainable health and wellness trend*.
Bull says
- ↑Q2 2026 revenue rose to ฿399 M, up 7.9% YoY, with net profit of ฿30.2 M
- ↑Achieved perfect 100-point AGM Checklist and Forbes Asia 'Best Under A Billion'
- ↑Dividend of ฿0.05/share approved, attracting income-focused investors
- ↑New production facility investment aims to boost capacity and margins
- ↑High earnings yield, strong profitability, and positive momentum factors support upside
- ↑Analysts’ earnings revisions and ROE remain favorable
Bear says
- ↓EPS flat at ฿0.05 despite revenue growth, limiting profitability gains
- ↓Insider sales from management weigh on market sentiment
- ↓Ongoing legal inquiries pose regulatory risk and potential costs
- ↓High leverage and poor earnings yield raise downturn vulnerability
- ↓Volatile health-beauty market and shifting consumer tastes threaten stability
- ↓Negative momentum or adverse earnings revisions could pressure shares